Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials.
Yasmin Luz Lima MesquitaIsabela Reis MarquesIsabela Reis MarquesSara Almeida CruzEduardo Messias Hirano PadrãoPedro Emanuel de Paula CarvalhoCaroliny Hellen Azevedo da SilvaRhanderson CardosoFilipe Azevedo MouraVladimir Vitalievich RafalskiyPublished in: International journal of obesity (2005) (2023)
CRD42022348576.